{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:55:33Z","timestamp":1793411733827,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"vor","delay-in-days":86,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"General Program of Guangxi Natural Science Foundation","award":["2025GXNSFBA069123"],"award-info":[{"award-number":["2025GXNSFBA069123"]}]},{"name":"National Natural Science Foundation Cultivation Project","award":["2026GPY0215"],"award-info":[{"award-number":["2026GPY0215"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"DOI":"10.1186\/s12931-026-03824-x","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T06:55:02Z","timestamp":1784530502000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["UHRF1 inhibits cuproptosis in lung adenocarcinoma via promoting FDX1 promoter methylation"],"prefix":"10.1186","volume":"27","author":[{"given":"Bin","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichen","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangrui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruyi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimin","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"key":"3824_CR1","first-page":"15","volume":"22","author":"L Su","year":"2022","unstructured":"Su L, Zhao J, Su H, Wang Y, Huang W, Jiang X, Gao S. CircRNAs in Lung Adenocarcinoma: Diagnosis and Therapy. Curr Gene Ther. 2022;22:15\u201322.","journal-title":"Curr Gene Ther"},{"key":"3824_CR2","doi-asserted-by":"crossref","unstructured":"Song Y, Kelava L, Kiss I. MiRNAs in Lung Adenocarcinoma: Role, Diagnosis, Prognosis, and Therapy. Int J Mol Sci. 2023;24:13302.","DOI":"10.3390\/ijms241713302"},{"key":"3824_CR3","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s12890-021-01549-9","volume":"21","author":"J Ning","year":"2021","unstructured":"Ning J, Jiang S, Li X, Wang Y, Deng X, Zhang Z, He L, Wang D, Jiang Y. GPC3 affects the prognosis of lung adenocarcinoma and lung squamous cell carcinoma. BMC Pulm Med. 2021;21:199.","journal-title":"BMC Pulm Med"},{"key":"3824_CR4","doi-asserted-by":"crossref","unstructured":"Chen Y, Zhou Y, Ren R, Chen Y, Lei J, Li Y. Harnessing lipid metabolism modulation for improved immunotherapy outcomes in lung adenocarcinoma. J Immunother Cancer. 2024;12:e008811.","DOI":"10.1136\/jitc-2024-008811"},{"key":"3824_CR5","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.abf0529","volume":"375","author":"P Tsvetkov","year":"2022","unstructured":"Tsvetkov P, Coy S, Petrova B, Dreishpoon M, Verma A, Abdusamad M, Rossen J, Joesch-Cohen L, Humeidi R, Spangler RD, et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science. 2022;375:1254\u201361.","journal-title":"Science"},{"key":"3824_CR6","doi-asserted-by":"publisher","first-page":"168317","DOI":"10.1016\/j.jmb.2023.168317","volume":"435","author":"M Zulkifli","year":"2023","unstructured":"Zulkifli M, Okonkwo AU, Gohil VM. FDX1 Is Required for the Biogenesis of Mitochondrial Cytochrome c Oxidase in Mammalian Cells. J Mol Biol. 2023;435:168317.","journal-title":"J Mol Biol"},{"key":"3824_CR7","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1186\/s12967-024-05277-6","volume":"22","author":"M Liu","year":"2024","unstructured":"Liu M, Wu S, Wu H, Zhou Y, Zhang X, Zhu D, Jiang J. Ferredoxin 1: a gatekeeper in halting lung adenocarcinoma progression through activation of the GPRIN2 signaling pathway. J Transl Med. 2024;22:510.","journal-title":"J Transl Med"},{"key":"3824_CR8","doi-asserted-by":"publisher","first-page":"749134","DOI":"10.3389\/fphar.2021.749134","volume":"12","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Ma Y, Guo X, Du Y, Zhu Q, Wang X, Duan C. FDX1 can Impact the Prognosis and Mediate the Metabolism of Lung Adenocarcinoma. Front Pharmacol. 2021;12:749134.","journal-title":"Front Pharmacol"},{"key":"3824_CR9","doi-asserted-by":"crossref","unstructured":"Kim A, Benavente CA. Oncogenic Roles of UHRF1 in Cancer. Epigenomes. 2024;8:26.","DOI":"10.3390\/epigenomes8030026"},{"key":"3824_CR10","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13046-016-0308-0","volume":"35","author":"X Wan","year":"2016","unstructured":"Wan X, Yang S, Huang W, Wu D, Chen H, Wu M, Li J, Li T, Li Y. UHRF1 overexpression is involved in cell proliferation and biochemical recurrence in prostate cancer after radical prostatectomy. J Exp Clin Cancer Res. 2016;35:34.","journal-title":"J Exp Clin Cancer Res"},{"key":"3824_CR11","first-page":"1554","volume":"7","author":"SP Gao","year":"2017","unstructured":"Gao SP, Sun HF, Li LD, Fu WY, Jin W. UHRF1 promotes breast cancer progression by suppressing KLF17 expression by hypermethylating its promoter. Am J Cancer Res. 2017;7:1554\u201365.","journal-title":"Am J Cancer Res"},{"key":"3824_CR12","doi-asserted-by":"publisher","first-page":"3966","DOI":"10.1038\/s41467-023-39591-2","volume":"14","author":"K Kostyrko","year":"2023","unstructured":"Kostyrko K, Roman M, Lee AG, Simpson DR, Dinh PT, Leung SG, Marini KD, Kelly MR, Broyde J, Califano A, et al. UHRF1 is a mediator of KRAS driven oncogenesis in lung adenocarcinoma. Nat Commun. 2023;14:3966.","journal-title":"Nat Commun"},{"key":"3824_CR13","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.3724\/abbs.2024148","volume":"56","author":"D Liu","year":"2024","unstructured":"Liu D, Du Q, Zhu Y, Guo Y, Guo Y. UHRF1 knockdown induces cell cycle arrest and apoptosis in breast cancer cells through the ZBTB16\/ANXA7\/Cyclin B1 axis. Acta Biochim Biophys Sin (Shanghai). 2024;56:1633\u201343.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"3824_CR14","doi-asserted-by":"publisher","first-page":"146","DOI":"10.14348\/molcells.2021.0001","volume":"44","author":"MJ Kim","year":"2021","unstructured":"Kim MJ, Lee HJ, Choi MY, Kang SS, Kim YS, Shin JK, Choi WS. UHRF1 Induces Methylation of the TXNIP Promoter and Down-Regulates Gene Expression in Cervical Cancer. Mol Cells. 2021;44:146\u201359.","journal-title":"Mol Cells"},{"key":"3824_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41389-022-00446-y","volume":"12","author":"Y Fu","year":"2023","unstructured":"Fu Y, Cao T, Zou X, Ye Y, Liu Y, Peng Y, Deng T, Yin L, Li X. AKT1 regulates UHRF1 protein stability and promotes the resistance to abiraterone in prostate cancer. Oncogenesis. 2023;12:1.","journal-title":"Oncogenesis"},{"key":"3824_CR16","doi-asserted-by":"crossref","unstructured":"Zhang H, Song Y, Yang C, Wu X. UHRF1 mediates cell migration and invasion of gastric cancer. Biosci Rep. 2018;38:BSR20181065.","DOI":"10.1042\/BSR20181065"},{"key":"3824_CR17","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.canlet.2019.03.024","volume":"452","author":"Q Hu","year":"2019","unstructured":"Hu Q, Qin Y, Ji S, Xu W, Liu W, Sun Q, Zhang Z, Liu M, Ni Q, Yu X, Xu X. UHRF1 promotes aerobic glycolysis and proliferation via suppression of SIRT4 in pancreatic cancer. Cancer Lett. 2019;452:226\u201336.","journal-title":"Cancer Lett"},{"key":"3824_CR18","doi-asserted-by":"publisher","first-page":"8069","DOI":"10.1111\/jcmm.15438","volume":"24","author":"Z Tu","year":"2020","unstructured":"Tu Z, Deng X, Hou S, Feng A, Zhang Q. UHRF1 predicts poor prognosis by triggering cell cycle in lung adenocarcinoma. J Cell Mol Med. 2020;24:8069\u201377.","journal-title":"J Cell Mol Med"},{"key":"3824_CR19","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/s41598-018-37258-3","volume":"9","author":"J Li","year":"2019","unstructured":"Li J, Wang R, Hu X, Gao Y, Wang Z, Li J, Wong J. Activated MEK\/ERK Pathway Drives Widespread and Coordinated Overexpression of UHRF1 and DNMT1 in Cancer cells. Sci Rep. 2019;9:907.","journal-title":"Sci Rep"},{"key":"3824_CR20","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13072-024-00540-y","volume":"17","author":"L Gu","year":"2024","unstructured":"Gu L, Fu Y, Li X. Roles of post-translational modifications of UHRF1 in cancer. Epigenetics Chromatin. 2024;17:15.","journal-title":"Epigenetics Chromatin"},{"key":"3824_CR21","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/j.semcancer.2022.09.007","volume":"86","author":"S Paul","year":"2022","unstructured":"Paul S, Ghosh S, Kumar S. Tumor glycolysis, an essential sweet tooth of tumor cells. Semin Cancer Biol. 2022;86:1216\u201330.","journal-title":"Semin Cancer Biol"},{"key":"3824_CR22","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13046-020-01629-4","volume":"39","author":"J Feng","year":"2020","unstructured":"Feng J, Li J, Wu L, Yu Q, Ji J, Wu J, Dai W, Guo C. Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma. J Exp Clin Cancer Res. 2020;39:126.","journal-title":"J Exp Clin Cancer Res"},{"key":"3824_CR23","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/s41419-022-05213-w","volume":"13","author":"K Cai","year":"2022","unstructured":"Cai K, Chen S, Zhu C, Li L, Yu C, He Z, Sun C. FOXD1 facilitates pancreatic cancer cell proliferation, invasion, and metastasis by regulating GLUT1-mediated aerobic glycolysis. Cell Death Dis. 2022;13:765.","journal-title":"Cell Death Dis"},{"key":"3824_CR24","doi-asserted-by":"publisher","first-page":"114301","DOI":"10.1016\/j.biopha.2023.114301","volume":"159","author":"W Yang","year":"2023","unstructured":"Yang W, Wang Y, Huang Y, Yu J, Wang T, Li C, Yang L, Zhang P, Shi L, Yin Y, et al. 4-Octyl itaconate inhibits aerobic glycolysis by targeting GAPDH to promote cuproptosis in colorectal cancer. Biomed Pharmacother. 2023;159:114301.","journal-title":"Biomed Pharmacother"},{"key":"3824_CR25","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1038\/s41418-023-01125-0","volume":"30","author":"C Xiong","year":"2023","unstructured":"Xiong C, Ling H, Hao Q, Zhou X. Cuproptosis: p53-regulated metabolic cell death? Cell Death Differ. 2023;30:876\u201384.","journal-title":"Cell Death Differ"},{"key":"3824_CR26","doi-asserted-by":"publisher","first-page":"105046","DOI":"10.1016\/j.jbc.2023.105046","volume":"299","author":"MB Dreishpoon","year":"2023","unstructured":"Dreishpoon MB, Bick NR, Petrova B, Warui DM, Cameron A, Booker SJ, Kanarek N, Golub TR, Tsvetkov P. FDX1 regulates cellular protein lipoylation through direct binding to LIAS. J Biol Chem. 2023;299:105046.","journal-title":"J Biol Chem"},{"key":"3824_CR27","doi-asserted-by":"publisher","first-page":"130872","DOI":"10.1016\/j.bbagen.2025.130872","volume":"1870","author":"Y Zhao","year":"2026","unstructured":"Zhao Y, Zheng R, Luo K, Zhao H, Xiang W. The CEBPA\/FDX1 axis elevates sensitivity to cuproptosis in lung adenocarcinoma cells. Biochim Biophys Acta Gen Subj. 2026;1870:130872.","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"3824_CR28","doi-asserted-by":"publisher","first-page":"6523","DOI":"10.1038\/s41467-023-42025-8","volume":"14","author":"L Sun","year":"2023","unstructured":"Sun L, Zhang Y, Yang B, Sun S, Zhang P, Luo Z, Feng T, Cui Z, Zhu T, Li Y, et al. Lactylation of METTL16 promotes cuproptosis via m(6)A-modification on FDX1 mRNA in gastric cancer. Nat Commun. 2023;14:6523.","journal-title":"Nat Commun"},{"key":"3824_CR29","doi-asserted-by":"publisher","first-page":"103302","DOI":"10.1016\/j.redox.2024.103302","volume":"75","author":"B Sun","year":"2024","unstructured":"Sun B, Ding P, Song Y, Zhou J, Chen X, Peng C, Liu S. FDX1 downregulation activates mitophagy and the PI3K\/AKT signaling pathway to promote hepatocellular carcinoma progression by inducing ROS production. Redox Biol. 2024;75:103302.","journal-title":"Redox Biol"},{"key":"3824_CR30","doi-asserted-by":"publisher","first-page":"e18655","DOI":"10.1016\/j.heliyon.2023.e18655","volume":"9","author":"G Chen","year":"2023","unstructured":"Chen G, Zhang J, Teng W, Luo Y, Ji X. FDX1 inhibits thyroid cancer malignant progression by inducing cuprotosis. Heliyon. 2023;9:e18655.","journal-title":"Heliyon"},{"key":"3824_CR31","doi-asserted-by":"publisher","first-page":"e2309984","DOI":"10.1002\/advs.202309984","volume":"11","author":"X Lu","year":"2024","unstructured":"Lu X, Chen X, Lin C, Yi Y, Zhao S, Zhu B, Deng W, Wang X, Xie Z, Rao S, et al. Elesclomol Loaded Copper Oxide Nanoplatform Triggers Cuproptosis to Enhance Antitumor Immunotherapy. Adv Sci (Weinh). 2024;11:e2309984.","journal-title":"Adv Sci (Weinh)"},{"key":"3824_CR32","doi-asserted-by":"crossref","unstructured":"Wu Y, Zhang W, Jiang S, Liu S, Su J, Sun L. LRPPRC-Driven Oxidative Phosphorylation Is Associated with Elesclomol-Induced Cuproptosis in Ovarian Cancer. Int J Mol Sci. 2025;27:451.","DOI":"10.3390\/ijms27010451"},{"key":"3824_CR33","doi-asserted-by":"crossref","unstructured":"Huo S, Wang Q, Shi W, Peng L, Jiang Y, Zhu M, Guo J, Peng D, Wang M, Men L et al. ATF3\/SPI1\/SLC31A1 Signaling Promotes Cuproptosis Induced by Advanced Glycosylation End Products in Diabetic Myocardial Injury. Int J Mol Sci. 2023;24:1667.","DOI":"10.3390\/ijms24021667"},{"key":"3824_CR34","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/s41419-025-07613-0","volume":"16","author":"Y Gu","year":"2025","unstructured":"Gu Y, Wang H, Xue W, Zhu L, Fu C, Zhang W, Mu G, Xia Y, Wei K, Wang J. Endoplasmic reticulum stress related super-enhancers suppress cuproptosis via glycolysis reprogramming in lung adenocarcinoma. Cell Death Dis. 2025;16:316.","journal-title":"Cell Death Dis"},{"key":"3824_CR35","doi-asserted-by":"publisher","first-page":"251","DOI":"10.17305\/bb.2025.12751","volume":"26","author":"XH Song","year":"2025","unstructured":"Song XH, Ding YH, Chen JS. Tumor glucose reprogramming suppresses cuproptosis: A review. Biomol Biomed. 2025;26:251\u201361.","journal-title":"Biomol Biomed"},{"key":"3824_CR36","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s12935-025-03864-1","volume":"25","author":"C Luo","year":"2025","unstructured":"Luo C, Wu X, Zhang S, Tan J, Huo Y, Zhang X, Ning B, Ye Y, Wang F. Cuproptosis: a novel therapeutic mechanism in lung cancer. Cancer Cell Int. 2025;25:231.","journal-title":"Cancer Cell Int"},{"key":"3824_CR37","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1186\/s13046-022-02485-0","volume":"41","author":"P Zheng","year":"2022","unstructured":"Zheng P, Zhou C, Lu L, Liu B, Ding Y. Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy. J Exp Clin Cancer Res. 2022;41:271.","journal-title":"J Exp Clin Cancer Res"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-026-03824-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-026-03824-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-026-03824-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T10:31:35Z","timestamp":1793269895000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-026-03824-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3824"],"URL":"https:\/\/doi.org\/10.1186\/s12931-026-03824-x","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"assertion":[{"value":"2 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Article is updated to correct the Funding information.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Animal experiments were performed under a project license (NO. KY-KJT-2024-46) granted by the ethics committee of Guangxi Academy of Medical Sciences and the People\u2019s Hospital of Guangxi Zhuang Autonomous Region, in compliance with institutional guidelines for the care and use of animals. Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"396"}}